Lonza reported FY16 results. Sales reached CHF4,132m (+8.7%), core EBITDA CHF918m (+15.8%), core EBIT CHF651m (+24.2%) and core profit CHF443m (+24.4%). EBITDA was up 8.7% to CHF848m, EBIT +13.6% to CHF486m and net up 8.1% to CHF301m. Net debt at the end of FY16 was CHF1,584m (vs CHF1,660m a year earlier). The dividend proposed will be CHF2.75 (vs CHF2.50). For FY17, the group anticipates mid single-digit sales growth, core EBITDA of CHF1bn and double-digit core EBIT growth.
25 Jan 2017
FY16 OK, all eyes on Capsugel now
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY16 OK, all eyes on Capsugel now
Lonza Group AG (0QNO:LON) | 0 0 0.0% | Mkt Cap: 22,735m
- Published:
25 Jan 2017 -
Author:
Fabrice Farigoule -
Pages:
2
Lonza reported FY16 results. Sales reached CHF4,132m (+8.7%), core EBITDA CHF918m (+15.8%), core EBIT CHF651m (+24.2%) and core profit CHF443m (+24.4%). EBITDA was up 8.7% to CHF848m, EBIT +13.6% to CHF486m and net up 8.1% to CHF301m. Net debt at the end of FY16 was CHF1,584m (vs CHF1,660m a year earlier). The dividend proposed will be CHF2.75 (vs CHF2.50). For FY17, the group anticipates mid single-digit sales growth, core EBITDA of CHF1bn and double-digit core EBIT growth.